ArticleScientific reports2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Laura Pizzuti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it